Targeted Drug Shrinks Tumors In Hard-To-Treat Cancer

A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.

Raccontata daforbes.com